Intermolecular to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per share in an all cash transaction
May 6 (Reuters) - Intermolecular Inc
Latest Key Developments inPharmaceuticals
- Aarey Drugs And Pharmaceuticals Gets Resignation Letter From CFO Rajesh P. Ghatalia.
- Novo Nordisk Files For US FDA Regulatory Approval Of Once-Weekly Semaglutide 2.4 Mg For Weight Management
- Vivimed Labs CEO Ramesh Krishnamurthy Given Additional Charge As CFO
- Clover Biopharmaceuticals Announces Positive Phase 1 Data For Its Adjuvanted S-Trimer Covid-19 Vaccine Candidates